Yilong Wang Selected Research

Ischemic Stroke

11/2022	No rebound effect after a course of clopidogrel in patients with acute TIA or minor stroke.
10/2022	Predictive values of baseline matrix metalloproteinase 9 levels in peripheral blood on 3-month outcomes of high-risk patients with minor stroke or transient ischemic attack.
10/2022	Rationale and design of a stepped wedge cluster randomised trial to improve acute reperfusion treatment quality for stroke: IMPROVE stroke care in China.
9/2022	Non-contrast head CT alone for thrombectomy in acute ischemic stroke: analysis of the ANGEL-ACT registry.
9/2022	Prevalence and In-hospital outcomes of diabetes among acute ischemic stroke patients in china: results from the Chinese Stroke Center Alliance.
6/2022	Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study.
3/2022	Association of triglyceride-glucose index and stroke recurrence among nondiabetic patients with acute ischemic stroke.
2/2022	Influence of coronavirus disease 2019 (COVID-19) on working flow, safety and efficacy outcome of mechanical thrombectomy for acute ischemic stroke with large vessel occlusion.
1/2022	Both Ends of Values in the Hemoglobin Spectrum Are Associated with Adverse Stroke Outcomes.
1/2022	Stress hyperglycemia is associated with in-hospital mortality in patients with diabetes and acute ischemic stroke.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yilong Wang Research Topics

Disease

178	Stroke (Strokes) 11/2022 - 01/2006
135	Ischemic Stroke 11/2022 - 01/2006
50	Transient Ischemic Attack 10/2022 - 05/2008
22	Hemorrhage 01/2022 - 07/2013
17	Diabetes Mellitus 01/2022 - 05/2008
15	Pathologic Constriction (Stenosis) 10/2021 - 01/2012
13	Atrial Fibrillation 05/2020 - 01/2013
13	Neoplasms (Cancer) 04/2020 - 05/2008
11	Cerebral Hemorrhage 08/2021 - 05/2008
10	Hypertension (High Blood Pressure) 01/2022 - 05/2009
10	Atherosclerosis 01/2022 - 01/2012
8	Insulin Resistance 03/2022 - 01/2017
7	Cognitive Dysfunction 05/2022 - 09/2012
7	Hyperglycemia 01/2022 - 11/2017
5	Embolic Stroke 12/2020 - 01/2013
4	Prediabetic State (Prediabetes) 08/2022 - 03/2012
4	COVID-19 02/2022 - 10/2020
4	Hematoma 01/2022 - 12/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2017
4	Heart Failure 05/2018 - 05/2013
4	Leukoaraiosis 11/2014 - 05/2009
3	Glucose Intolerance 08/2022 - 05/2010
3	Inflammation (Inflammations) 06/2022 - 01/2019
3	Deglutition Disorders (Dysphagia) 01/2022 - 05/2013
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 03/2015
3	Cerebral Infarction 01/2021 - 03/2019
3	Infarction (Infarctions) 01/2021 - 03/2012
3	Chronic Renal Insufficiency 12/2018 - 01/2014
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2017 - 06/2011
2	Wounds and Injuries (Trauma) 03/2022 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 05/2013
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 01/2020
2	Cerebral Small Vessel Diseases 01/2021 - 01/2014
2	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 09/2012
2	Obesity 05/2019 - 10/2017
2	Tuberculosis (Tuberculoses) 01/2019 - 01/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2018 - 01/2017
2	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 08/2018 - 06/2016

Drug/Important Bio-Agent (IBA)

52	Clopidogrel (Plavix)FDA Link 11/2022 - 07/2013
43	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2006
35	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 05/2010
18	Biomarkers (Surrogate Marker)IBA 06/2022 - 03/2015
17	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 02/2009
15	Cytochrome P-450 CYP2C19IBA 11/2022 - 07/2016
11	C-Reactive ProteinIBA 06/2022 - 01/2013
11	danaparoid (Orgaran)FDA Link 01/2022 - 07/2010
11	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 05/2008
11	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2012
10	TicagrelorIBA 01/2022 - 01/2017
9	Triglycerides (Triacylglycerol)IBA 03/2022 - 11/2015
9	oxidized low density lipoproteinIBA 01/2021 - 06/2011
7	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2016
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 10/2015
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2014
6	Indicators and Reagents (Reagents)IBA 11/2018 - 01/2014
5	CholesterolIBA 01/2022 - 06/2011
5	LipidsIBA 01/2022 - 12/2016
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2018
4	AnticoagulantsIBA 01/2021 - 05/2008
3	Therapeutic UsesIBA 11/2022 - 01/2021
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 06/2022 - 11/2015
3	Insulin (Novolin)FDA Link 01/2022 - 05/2014
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
3	HDL CholesterolIBA 01/2022 - 01/2021
3	LDL CholesterolIBA 01/2021 - 10/2015
3	HDL LipoproteinsIBA 01/2021 - 12/2017
3	EdaravoneIBA 01/2021 - 10/2018
3	LDL Lipoproteins (beta Lipoproteins)IBA 12/2020 - 05/2009
3	Biological ProductsIBA 04/2020 - 09/2016
3	HomocysteineIBA 01/2020 - 07/2010
3	RivaroxabanIBA 06/2018 - 09/2016
3	AlbuminsIBA 11/2017 - 03/2015
3	Warfarin (Coumadin)FDA LinkGeneric 02/2016 - 05/2014
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2022 - 11/2020
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 06/2022 - 02/2020
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2022 - 02/2020
2	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2021
2	HydrogelsIBA 03/2022 - 01/2021
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2021
2	ORALIT (ORS)IBA 01/2022 - 01/2019
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2022 - 08/2009
2	VaccinesIBA 06/2021 - 01/2018
2	Lipoprotein(a)IBA 01/2021 - 12/2019
2	Adenosine Diphosphate (ADP)IBA 01/2021 - 10/2017
2	LipopolysaccharidesIBA 01/2021 - 08/2017
2	Carbon DioxideIBA 11/2020 - 10/2020
2	Protein CoronaIBA 01/2020 - 12/2018
2	EnzymesIBA 01/2020 - 10/2019
2	AntioxidantsIBA 01/2020 - 10/2019
2	Factor Xa InhibitorsIBA 06/2018 - 09/2016

Therapy/Procedure

73	Therapeutics 11/2022 - 02/2009
23	Secondary Prevention 09/2022 - 01/2006
11	Thrombectomy 09/2022 - 06/2016
6	Stents 10/2021 - 10/2015
6	Length of Stay 01/2017 - 12/2011
3	Punctures 01/2021 - 10/2017
3	Thrombolytic Therapy 12/2020 - 06/2011
2	Intravenous Injections 05/2022 - 10/2018
2	Anesthesia 01/2020 - 10/2017